MADISON WARREN: Open Payments
NPI 1740928936 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 60 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $415 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 21 | $580 |
| Gilead Sciences, Inc. | 21 | $526 |
| EMD Serono, Inc. | 3 | $83 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 2 | $39 |
| Napo Pharmaceuticals Inc | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| PFIZER INC. | 1 | $17 |
Products named: CABENUVA, DOVATO, PIFELTRO, AIRSUPRA, Ozempic, MAVYRET, Mytesi, Kerendia.
Industry payments across AZ — which companies pay providers there.
